Patterns of Failure in Cutaneous Head and Neck Melanoma Following Negative Sentinel Lymph Node Biopsy: A Retrospective Cohort Study
The American Surgeon™ · 2025
DOI: 10.1177/00031348251323707 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The American Surgeon™, 2025. Verfasst von Phillip Staibano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada. Hauptthemen laut MEDLINE: Melanoma, Sentinel Lymph Node Biopsy, Skin Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cutaneous head and neck melanoma (cHNM) has a high rate of false-negative sentinel lymph node biopsy (SLNB) and up to a 25% risk of recurrence despite negative SLNB. The aim of this study was to investigate the pattern of melanoma recurrence in patients with cHNM with negative SLNB.
Methods
A retrospective cohort study of consecutive cHNM patients at a tertiary care centre from 2014-2022. We included all cHNM patients with negative SLNB. All patients were categorized into Breslow thickness >2 mm and ≤2 mm and extracted information pertaining to histopathological characteristics and the presence and type of disease recurrences. We performed multivariable analysis using logistic and cox regression. We used an alpha of 0.05 and all statistical analyses were performed using R software.
Results
Overall, 167 patients met eligibility criteria and of these, 53.5% patients had cHNM ≤2 mm thick and 46.7% had lesions >2 mm thick. The overall recurrence rate was 29.3%. Multivariable analysis demonstrated that Breslow thickness [aOR: 5.89 (95% CI: 1.37, 32.3), P = 0.02] was associated with distant recurrence. Multivariable cox regression also identified that pathological ulceration [aHR: 3.17 (95% CI: 1.61, 7.66), P = 0.01] predicted time to distant recurrence. The SLNB false omission rate was 3.6% (95% CI: 1.3%, 7.7%).
Conclusion
SLNB-negative cHNM patients with high-risk pathological features may benefit from adjuvant immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.
- Department of Health Methodology, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
ORCID-Profile: Phillip Staibano
Zitieren
APA
Staibano, P., Xie, M., Abdallah, Z., Nguyen, S., Au, M., Zhou, K., Bensky, H., Gupta, M. K., Choi, D. L., Lewis, T. A., Young, J. E. M. T., & Zhang, H. (2025). Patterns of Failure in Cutaneous Head and Neck Melanoma Following Negative Sentinel Lymph Node Biopsy: A Retrospective Cohort Study. The American Surgeon™. https://doi.org/10.1177/00031348251323707
Vancouver
Staibano P, Xie M, Abdallah Z, Nguyen S, Au M, Zhou K, et al. Patterns of Failure in Cutaneous Head and Neck Melanoma Following Negative Sentinel Lymph Node Biopsy: A Retrospective Cohort Study. The American Surgeon™. 2025. doi:10.1177/00031348251323707
BibTeX
@article{Staibano2025,
author = {Staibano, Phillip and Xie, Michael and Abdallah, Zahra and Nguyen, Sofia and Au, Michael and Zhou, Kelvin and Bensky, Hailey and Gupta, Michael K and Choi, David L and Lewis, Trevor A and Young, J E M Ted and Zhang, Han},
title = {Patterns of Failure in Cutaneous Head and Neck Melanoma Following Negative Sentinel Lymph Node Biopsy: A Retrospective Cohort Study},
journal = {The American Surgeon™},
year = {2025},
doi = {10.1177/00031348251323707}
}
EUVIMED